…researchers [adding] worry…
…the use of psychedelics… [are historically] prevalent outside of clinical trials.
The trajectory of cannabis looked pretty similar. After years of the plant being buried under a [unconstitutional and unjust] reputation, legal restrictions began to loosen after new research showed promising medical applications. What followed was an explosion of highly branded, startup-lingo-laden cannabis companies, which pushed the once-illicit drug to the status of luxury lifestyle item. Beauty, beverage, and edible products cropped up everywhere, peppered with health claims that almost seemed beside the point… Many attribute the success of psychedelics to two mysterious and subjective occurrences unique to psychedelics: ego dissolution, or the complete loss of one’s sense of self, and “mystical-type experiences,” or hallucinogenic encounters with a divine or spiritual entity. In studies on the effects of psychedelics on depression, participants who experienced these states saw the strongest and longest-lasting improvements, and many count them as some of the most important and life-changing experiences of their lives … researchers… worry that in order to turn a profit, these [medical] protocols [and for-profits] might not live up to the standards needed to really deliver results – and they could be so expensive and exclusive that the people who need these interventions most might not be able to access them.
Original Article (Medium):
Medical researchers worry silicon valley could screw up psychedelics
Artwork Fair Use: Public Domain